Commonly used methods for determining protein structure, including X-ray crystallography and single-particle reconstruction, often provide a single and unique three-dimensional (3D) structure. However, in these methods, the protein dynamics and flexibility/fluctuation remain mostly unknown. Here, we utilized advances in electron tomography (ET) to study the antibody flexibility and fluctuation through structural determination of individual antibody particles rather than averaging multiple antibody particles together. Through individual-particle electron tomography (IPET) 3D reconstruction from negatively-stained ET images, we obtained 120 ab-initio 3D density maps at an intermediate resolution (~1–3 nm) from 120 individual IgG1 antibody particles. Using these maps as a constraint, we derived 120 conformations of the antibody via structural flexible docking of the crystal structure to these maps by targeted molecular dynamics simulations. Statistical analysis of the various conformations disclosed the antibody 3D conformational flexibility through the distribution of its domain distances and orientations. This blueprint approach, if extended to other flexible proteins, may serve as a useful methodology towards understanding protein dynamics and functions.
Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesterol esters (CE) from atheroprotective high-density lipoproteins (HDL) to atherogenic low-density lipoproteins (LDL). CETP inhibition has been regarded as a promising strategy for increasing HDL levels and subsequently reducing the risk of cardiovascular diseases (CVD). Although the crystal structure of CETP is known, little is known regarding how CETP binds to HDL. Here, we investigated how various HDL-like particles interact with CETP by electron microscopy and molecular dynamics simulations. Results showed that CETP binds to HDL via hydrophobic interactions rather than protein-protein interactions. The HDL surface lipid curvature generates a hydrophobic environment, leading to CETP hydrophobic distal end interaction. This interaction is independent of other HDL components, such as apolipoproteins, cholesteryl esters and triglycerides. Thus, disrupting these hydrophobic interactions could be a new therapeutic strategy for attenuating the interaction of CETP with HDL.
Background
Negative-staining (NS), a rapid, simple and conventional technique of electron microscopy (EM), has been commonly used to initially study the morphology and structure of proteins for half a century. Certain NS protocols however can cause artifacts, especially for structurally flexible or lipid-related proteins, such as lipoproteins. Lipoproteins were often observed in the form of rouleau as lipoprotein particles appeared to be stacked together by conventional NS protocols. The flexible components of lipoproteins, i.e. lipids and amphipathic apolipoproteins, resulted in the lipoprotein structure being sensitive to the NS sample preparation parameters, such as operational procedures, salt concentrations, and the staining reagents.
Scope of review
The most popular NS protocols that have been used to examine lipoprotein morphology and structure were reviewed.
Major conclusions
The comparisons show that an optimized NS (OpNS) protocol can eliminate the rouleau artifacts of lipoproteins, and that the lipoproteins are similar in size and shape as statistically measured from two EM methods, OpNS and cryo-electron microscopy (cryo-EM). OpNS is a high-throughput, high-contrast and high-resolution (near 1 nm, but rarely better than 1 nm) method which has been used to discover the mechanics of a small protein, 53 kDa cholesterol ester transfer protein (CETP), and the structure of an individual particle of a single protein by individual-particle electron tomography (IPET), i.e. a 14 Å-resolution IgG antibody three-dimensional map.
General significance
It is suggested that OpNS can be used as a general protocol to study the structure of proteins, especially highly dynamic proteins with equilibrium-fluctuating structures.
Peptides show much promise as potent and selective drug candidates. Fusing peptides to a scaffold monoclonal antibody produces a conjugated antibody which has the advantages of peptide activity yet also has the pharmacokinetics determined by the scaffold antibody. However, the conjugated antibody often has poor binding affinity to antigens that may be related to unknown structural changes. The study of the conformational change is difficult by conventional techniques because structural fluctuation under equilibrium results in multiple structures co-existing. Here, we employed our two recently developed electron microscopy (EM) techniques: optimized negative-staining (OpNS) EM and individual-particle electron tomography (IPET). Two-dimensional (2D) image analyses and three-dimensional (3D) maps have shown that the domains of antibodies present an elongated peptide-conjugated conformational change, suggesting that our EM techniques may be novel tools to monitor the structural conformation changes in heterogeneous and dynamic macromolecules, such as drug delivery vehicles after pharmacological synthesis and development.
DNA base pairing has been used for many years to direct the arrangement of inorganic
nanocrystals into small groupings and arrays with tailored optical and electrical
properties. The control of DNA-mediated assembly depends crucially on a better
understanding of three-dimensional structure of DNA-nanocrystal-hybridized building
blocks. Existing techniques do not allow for structural determination of these
flexible and heterogeneous samples. Here we report cryo-electron microscopy and
negative-staining electron tomography approaches to image, and three-dimensionally
reconstruct a single DNA-nanogold conjugate, an 84-bp double-stranded DNA with two
5-nm nanogold particles for potential substrates in plasmon-coupling experiments. By
individual-particle electron tomography reconstruction, we obtain 14 density maps at
∼2-nm resolution. Using these maps as constraints, we derive 14
conformations of dsDNA by molecular dynamics simulations. The conformational
variation is consistent with that from liquid solution, suggesting that
individual-particle electron tomography could be an expected approach to study
DNA-assembling and flexible protein structure and dynamics.
Background: Calsyntenin-3 (Cstn3) promotes synapse development, controversially interacting with neurexin 1␣ (n1␣). Results: Cstn3 binds n1␣ directly, and its structure adopts multiple forms. Conclusion: Cstn3 interacts with n1␣ via a novel mechanism and can produce distinct trans-synaptic bridges with n1␣. Significance: A complex portfolio of molecular interactions between proteins implicated in autism spectrum disorder and schizophrenia guide synapse development.
Recently, individual reduced-symmetry metal nanostructures and their plasmonic properties have been studied extensively. However, little attention has been paid to the approach to fabricating ordered reduced-symmetry metal nanostructure arrays. In this paper, a novel perforated silver nanocap array with high surface-enhanced Raman scattering (SERS) activity and fluorescence suppression is reported. The array is fabricated by electron beam evaporating Ag onto the perforated barrier layer side of a hard anodization (HA) anodic aluminum oxide (AAO) template. The morphology and optical property of the perforated silver nanocap array are characterized by an atomic force microscope (AFM), a scanning electron microscope (SEM), and absorption spectra. The results of SERS measurements reveal that the perforated silver nanocap array offers high SERS activity and fluorescence suppression compared with an imperforated silver nanocap array.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.